pfizer

The center’s director, Dr. Rochelle Walensky, adopted a panel’s recommendation Thursday.

Pfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by late May or early June.

President Joe Biden and his administration want Americans and their doctors to know that the country has an ample supply of the life-saving COVID-19 antiviral treatment Paxlovid and that it no longer needs to be rationed

Pfizer and its partner BioNTech said Thursday new data shows its kid-sized booster shot helps healthy 5- to 11-year-olds rev up virus-fighting antibodies.

Pfizer wants to expand its COVID-19 booster shots to healthy 5- to 11-year-olds

Many Americans can now get a second COVID-19 booster, but it’s hard to tell who really needs another shot right now and who could wait.

The U.N.-backed Medicines Patent Pool says that nearly three dozen companies worldwide will soon start making generic versions of Pfizer’s coronavirus pill

Pfizer and its partner BioNTech asked U.S. regulators to authorize an additional booster dose of their COVID-19 vaccine for seniors

However, the Pfizer shots still offered protection against serious illness from COVID, the researchers found.

Pfizer said it believes three doses “may provide a higher level of protection in this age group.”

The FDA said it will wait for data on how well a third shot works for the youngest age group. Pfizer said in a statement that it expected the data by early April.

Pfizer on Tuesday asked U.S. regulators to authorize extra-low doses of its COVID-19 vaccine for children under age 5.

The nation’s 19 million children under 5 are the only group not yet eligible for vaccination against the coronavirus.

U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old.

Pfizer announced Tuesday it has launched a clinical trial to test an updated COVID-19 vaccine that targets the omicron variant.

Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant

Three new U.S. studies offer more evidence that the COVID-19 vaccines are standing up to the omicron variant, at least among people who have gotten booster shots

Vaccines still offer strong protection against serious illness from any type of COVID-19, including the highly contagious omicron variant, especially after a booster.

The Centers for Disease Control and Prevention updated guidelines for Pfizer COVID-19 boosters, shortening the time from second dose to booster to five months.

The CDC also recommended that kids ages 5 to 11 with moderately or severely weakened immune systems receive an additional dose 28 days after their second Pfizer shot